1st Quarter - Report

INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA

Firm
Client
Income
—
Expenses
$97,072
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; Physician payments; Medicaid and Medicare, including Medicare Prescription Drug Coverage; Average Sales Price; Competitive Acquisition Program; and Healthcare Reform.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate
JASON SCULL Program Officer for Clinical Affairs
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

Medical liability; Antimicrobial resistance research; Infectious diseases product research and development; Unnecessary regulatory burdens placed on medical research; Support for evidence-based decision making.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medical Association

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); SENATE

Health Issues HCR

Infectious diseases; drug and vaccine research and development; antimicrobial resistance; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues; Ryan White reauthorization; Strategies to Address Antimicrobial Resistance Act.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medicine Association Policy Officer
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources & Services Administration, Food & Drug Administration and global programs for various infectious diseases related issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS V.P. Public Policy & Government Relations
KIMBERLY ANN MILLER HIV Medical Association Policy Officer
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medical Association

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Affiliated organisations

OrganisationLocation
HIV MEDICINE ASSOCIATION Arlington, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.